Why the closure of an FDA office may impact generics manufacturers — and everyday Americans

Taking stock of the drug industry, from the lab to the medicine chest

April 9, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Why the closure of an FDA office may impact generics manufacturers — and everyday Americans "It's a tiny thing in the beginning, but it will have a big effect years down the road," said industry expert Kurt Karst. By Ed Silverman On an RFK Jr. road show, MAHA goals take precedence. Measles prevention less so Robert Kennedy Jr. plays up victories in nonfluoridated water and nutrition, plays down measles while away from layoff-wracked agencies in D.C. By Lev Facher STAT+ | AI agents in health care: Everything you need to know, but didn't know how to ask AI agents, which marry artificial intelligence with other programs, are making progress in health care, but the hype is still ahead of real-world results. By Brittany Trang NIH data ban blocks researchers in China, Russia, elsewhere Today's biotech news covers Trump tariffs placed on pharmaceuticals, and the NIH data ban blocking researchers in China, Russia, elsewhere. By Meghana Keshavan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser